Browsing Tag
NASDAQ
287 posts
Can Heidrick & Struggles’ $1.3bn buyout fuel its global leadership ambitions?
Heidrick & Struggles goes private in a $1.3 billion Advent–Corvex deal. Find out how this move could reshape global talent advisory.
How Lobo Technologies’ first German order for an EEC-certified electric tricycle could drive its EV growth narrative
Find out how Lobo Technologies’ first EEC-certified tricycle order in Germany could reshape its European electric mobility expansion strategy.
Moleculin hits key inflection point as pivotal MIRACLE Phase 3 AML trial completes treatment for first 45 patients
Find out how Moleculin Biotech’s pivotal MIRACLE Phase 3 milestone for Annamycin could reshape treatment for relapsed AML as Q1 2026 data approaches.
Pioneer Power Solutions introduces PRYMUS to cut AI data center power timelines from years to months
Learn how Pioneer Power Solutions’ PRYMUS fast-deploy power platform is reshaping AI data center timelines and what it means for infrastructure investors.
FDA grants RMAT designation to Senti Biosciences’ SENTI-202 after strong early AML trial results
Discover how Senti Biosciences’ SENTI-202 earned FDA RMAT designation after strong AML trial data and what it means for patients and investors.
Why Alcon raised its bid for STAAR Surgical and dropped matching rights in amended merger deal
Find out how Alcon raised its cash bid for STAAR Surgical and removed matching rights to secure a $1.6 billion refractive-technology acquisition.
ZenaTech acquires Casado Design to tap UK telecom tower design and 5G infrastructure via drone-as-a-service
Find out how ZenaTech’s Casado Design acquisition opens the UK telecom tower market and accelerates 5G infrastructure with drone-as-a-service.
Greenlane expands Berachain bet with $8m BERA purchase while holding $32m in cash and stablecoins
Discover how Greenlane is reshaping its balance sheet with an $8 million BERA purchase while holding $32 million in reserves for its Berachain treasury strategy.
$125m SPAC IPO puts Leapfrog Acquisition Corp in race for high-value energy and critical infrastructure targets
Leapfrog Acquisition Corp raised $125 million in a Nasdaq SPAC IPO to target global energy supply chain and critical-minerals assets.
Kala Bio launches $10m registered direct financing amid balance sheet reset and dilution concerns
Find out how Kala Bio’s $10 million at-the-market stock offering under Nasdaq rules is reshaping its balance sheet, dilution risk, and survival strategy.